Matsue Kosei (Kosei Matsue)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 44

Top Topics

Acute Myeloid Leukemia

Computed Tomography

Multiple Myeloma

Clinical Practice

Top Venues

International journal of hematology

British journal of haematology

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Daisuke Ikeda, Mitsuaki Oura, Atsushi Uehara, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Youichi Machida, Matsue Kosei
Real-world applicability of the International Metabolic Prognostic Index in DLBCL: a validation cohort study. Blood advances 8 (8) (2024)
Kentaro Narita, Akinao Okamoto, Sachiko Iba, Rikako Tabata, Daisuke Ikeda, Mitsuaki Oura, Atsushi Uehara, Masami Takeuchi, Kengo Takeuchi, Akihiro Tomita, Matsue Kosei
Analysis of the clinical features and outcomes of relapsed intravascular large B-cell lymphoma: a single center study. Leukemia & lymphoma (2024)
Daisuke Ikeda, Mitsuaki Oura, Atsushi Uehara, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Youichi Machida, Matsue Kosei
Real-world applicability of the International Metabolic Prognostic Index in DLBCL: a validation cohort study. Blood advances 8 (8) (2024)
Daisuke Ikeda, Mitsuaki Oura, Atsushi Uehara, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Youichi Machida, Matsue Kosei
Real-world applicability of the international metabolic prognostic index in DLBCL: a validation cohort study. Blood advances (2024)
Daisuke Ikeda, Toshiki Terao, Mitsuaki Oura, Atsushi Uehara, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Youichi Machida, Matsue Kosei
Analysis of baseline circulating tumor cells integrated with PET/CT findings in transplant-ineligible multiple myeloma. Blood advances 8 (1) (2023)
Ami Fukumoto, Shinnosuke Sugihara, Kurumi Seki, Masami Takeuchi, Tomo Suzuki, Matsue Kosei
Kidney involvement of chronic active Epstein-Barr virus infection. EJHaem 4 (1) (2023)
Daisuke Ikeda, Toshiki Terao, Mitsuaki Oura, Atsushi Uehara, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Youichi Machida, Matsue Kosei
Analysis of baseline circulating tumor cells integrated with PET/CT findings in transplant-ineligible multiple myeloma. Blood advances 8 (1) (2023)
Ami Fukumoto, Shinnosuke Sugihara, Kurumi Seki, Masami Takeuchi, Tomo Suzuki, Matsue Kosei
Kidney involvement of chronic active Epstein-Barr virus infection. EJHaem 4 (1) (2023)
Daisuke Ikeda, Matsue Kosei
Disseminated nontuberculous mycobacterial infection prior to hematopoietic stem cell transplantation: A case of successful treatment. Transplant infectious disease : an official journal of the Transplantation Society (2023)
Takafumi Tsushima, Toshiki Terao, Kentaro Narita, Ami Fukumoto, Daisuke Ikeda, Yuya Kamura, Ayumi Kuzume, Rikako Tabata, Daisuke Miura, Masami Takeuchi, Matsue Kosei
Clinical Characteristics and Outcomes of Cyclin D1-Positive AL Amyloidosis. American journal of clinical pathology (2023)
Ami Fukumoto, Kentaro Narita, Daisuke Ikeda, Yuka Uesugi, Rikako Tabata, Daisuke Miura, Masami Takeuchi, Matsue Kosei
Safety and efficacy of venetoclax for acute myeloid leukaemia in real-world clinical practice. Japanese journal of clinical oncology (2023)
Daisuke Ikeda, Toshiki Terao, Mitsuaki Oura, Atsushi Uehara, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Youichi Machida, Matsue Kosei
Analysis of baseline circulating tumor cells integrated with PET/CT findings in transplant-ineligible multiple myeloma. Blood advances 8 (1) (2023)
Toshiki Terao, Takafumi Tsushima, Daisuke Ikeda, Ami Fukumoto, Yuya Kamura, Ayumi Kuzume, Rikako Tabata, Daisuke Miura, Kentaro Narita, Masami Takeuchi, Matsue Kosei
Limited efficacy of high-dose methotrexate to prevent the central nervous system relapse in patients with IVLBCL. Leukemia & lymphoma (2022)
Toshiki Terao, Matsue Kosei
Progress of modern imaging modalities in multiple myeloma. International journal of hematology 115 (6) (2022)
Daisuke Ikeda, Toshiki Terao, Ami Fukumoto, Yuka Uesugi, Rikako Tabata, Ayumi Kuzume, Takafumi Tsushima, Daisuke Miura, Kentaro Narita, Masami Takeuchi, Takeshi Yamashita, Hiroyuki Takamatsu, Matsue Kosei
Antibody status following booster vaccination against SARS-CoV-2 virus in patients with haematologic malignancies. British journal of haematology (2022)
Toshiki Terao, Takeshi Yamashita, Ami Fukumoto, Yuya Kamura, Daisuke Ikeda, Ayumi Kuzume, Rikako Tabata, Takafumi Tsushima, Daisuke Miura, Kentaro Narita, Masami Takeuchi, Masahiro Doi, Yuka Umezawa, Yoshihito Otsuka, Hiroyuki Takamatsu, Matsue Kosei
Low clinical protective response to SARS-CoV-2 mRNA COVID-19 vaccine in patients with multiple myeloma. International journal of hematology 115 (5) (2022)
Toshiki Terao, Takafumi Tsushima, Daisuke Miura, Daisuke Ikeda, Ami Fukumoto, Ayumi Kuzume, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Matsue Kosei
Carfilzomib-induced thrombotic microangiopathy is underestimated in clinical practice: A report of five patients and literature review. Leukemia & lymphoma 63 (5) (2022)
Daisuke Ikeda, Takafumi Tsushima, Ami Fukumoto, Ayumi Kuzume, Rikako Tabata, Toshiki Terao, Daisuke Miura, Kentaro Narita, Masami Takeuchi, Koichi Honma, Matsue Kosei
Rapid liver atrophy and refractory ascites due to hepatoportal sclerosis in a patient after haploidentical stem cell transplantation. Leukemia & lymphoma 63 (6) (2022)
Takafumi Tsushima, Toshiki Terao, Kentaro Narita, Ami Fukumoto, Daisuke Ikeda, Yuya Kamura, Ayumi Kuzume, Rikako Tabata, Daisuke Miura, Masami Takeuchi, Matsue Kosei
Antibody response to COVID-19 vaccine in 130 recipients of hematopoietic stem cell transplantation. International journal of hematology 115 (5) (2022)
Matsue Kosei, Kazutaka Sunami, Morio Matsumoto, Junya Kuroda, Isamu Sugiura, Hiromi Iwasaki, Weiyuan Chung, Shigeki Kuwayama, Mitsufumi Nishio, Kim Lee, Shinsuke Iida
Pomalidomide, dexamethasone, and daratumumab in Japanese patients with relapsed or refractory multiple myeloma after lenalidomide-based treatment. International journal of hematology 116 (1) (2022)
Manabu Fujisawa, Tran B Nguyen, Yoshiaki Abe, Yasuhito Suehara, Kota Fukumoto, Sakurako Suma, Kenichi Makishima, Chihiro Kaneko, Yen T M Nguyen, Kensuke Usuki, Kentaro Narita, Matsue Kosei, Naoya Nakamura, Shumpei Ishikawa, Fumihito Miura, Takashi Ito, Ayako Suzuki, Yutaka Suzuki, Seiya Mizuno, Satoru Takahashi, Shigeru Chiba, Mamiko Sakata-Yanagimoto
Clonal germinal center B cells function as a niche for T-cell lymphoma. Blood 140 (18) (2022)
Ami Fukumoto, Daisuke Miura, Matsue Kosei
Successful allogeneic hematopoietic stem cell transplantation in a patient with acute myeloid leukemia and preexisting pulmonary nocardiosis. Transplant infectious disease : an official journal of the Transplantation Society (2022)
Toshiki Terao, Takashi Naduka, Daisuke Ikeda, Ami Fukumoto, Yuya Kamura, Ayumi Kuzume, Rikako Tabata, Takafumi Tsushima, Daisuke Miura, Kentaro Narita, Masami Takeuchi, Matsue Kosei
Depletion of CD38-positive regulatory T cells by anti-CD38 monoclonal antibodies induces a durable response to SARS-CoV-2 vaccination in patients with plasma cell dyscrasia. British journal of haematology 197 (4) (2022)
Kentaro Narita, So Nakaji, Rikako Tabata, Toshiki Terao, Ayumi Kuzume, Takafumi Tsushima, Daisuke Ikeda, Ami Fukumoto, Daisuke Miura, Masami Takeuchi, Masahiro Doi, Yuka Umezawa, Yoshihito Otsuka, Hiroyuki Takamatsu, Matsue Kosei
Antibody response to COVID-19 vaccination in patients with lymphoma. International journal of hematology 115 (5) (2022)
Ami Fukumoto, Toshiki Terao, Ayumi Kuzume, Rikako Tabata, Takafumi Tsushima, Daisuke Miura, Daisuke Ikeda, Yuya Kamura, Kentaro Narita, Masami Takeuchi, Matsue Kosei
Management of lymphoma-associated chylothorax by interventional radiology and chemotherapy: a report of five cases. International journal of hematology 116 (4) (2022)
Daisuke Ikeda, Matsue Kosei
Non-crystalline light chain proximal tubulopathy without renal Fanconi syndrome in a patient with IgD-λ multiple myeloma. British journal of haematology (2021)
Akihiro Kitadate, Toshiki Terao, Kentaro Narita, Sho Ikeda, Yuto Takahashi, Takafumi Tsushima, Daisuke Miura, Masami Takeuchi, Naoto Takahashi, Matsue Kosei
Multiple myeloma with t(11;14)-associated immature phenotype has lower CD38 expression and higher BCL2 dependence. Cancer science 112 (9) (2021)
Ayumi Kuzume, Rikako Tabata, Toshiki Terao, Takafumi Tsushima, Daisuke Miura, Kentaro Narita, Masami Takeuchi, Matsue Kosei
Safety and efficacy of daratumumab in patients with multiple myeloma and severe renal failure. British journal of haematology 193 (4) (2021)
Toshiki Terao, Youichi Machida, Takafumi Tsushima, Daisuke Miura, Kentaro Narita, Akihiro Kitadate, Masami Takeuchi, Matsue Kosei
Pre-treatment metabolic tumour volume and total lesion glycolysis are superior to conventional positron-emission tomography/computed tomography variables for outcome prediction in patients with newly diagnosed multiple myeloma in clinical practice. British journal of haematology 191 (2) (2020)
Matsue Kosei, Yoshiaki Abe, Kentaro Narita, Hiroki Kobayashi, Akihiro Kitadate, Daisuke Miura, Masami Takeuchi, Kengo Takeuchi
Bone marrow infiltration pattern in patients with intravascular large B-cell lymphoma diagnosed by random skin biopsy. EJHaem 1 (1) (2020)
Toshiki Terao, Hiroya Ashimine, Naoko Tsuyama, Daisuke Ikeda, Ayumi Kuzume, Rikako Tabata, Takafumi Tsushima, Daisuke Miura, Kentaro Narita, Masami Takeuchi, Kengo Takeuchi, Matsue Kosei
Development of BCR-ABL1-positive ɤδ T-cell leukemia after treatment for thymoma type B1. Leukemia & lymphoma 62 (5) (2020)
Akihiro Kitadate, Kentaro Narita, Kouta Fukumoto, Toshiki Terao, Takafumi Tsushima, Hiroki Kobayashi, Yoshiaki Abe, Daisuke Miura, Masami Takeuchi, Youichi Machida, Matsue Kosei
Baseline total lesion glycolysis combined with interim positron emission tomography-computed tomography is a robust predictor of outcome in patients with peripheral T-cell lymphoma. Cancer medicine 9 (15) (2020)
Toshiki Terao, Takafumi Tsushima, Daisuke Miura, Kentaro Narita, Masami Takeuchi, Matsue Kosei
Social frailty predicts worse outcomes in patients with multiple myeloma: A novelty in an old approach. EJHaem 1 (1) (2020)
Hiroki Kobayashi, Toshiki Terao, Takafumi Tsushima, Yoshiaki Abe, Daisuke Miura, Kentaro Narita, Akihiro Kitadate, Masami Takeuchi, Matsue Kosei
Association between serum erythropoietin levels and renal reversibility in patients with renal impairment from multiple myeloma. Cancer medicine 9 (12) (2020)
Takashi Kumagai, Chiaki Nakaseko, Kaichi Nishiwaki, Chikashi Yoshida, Kazuteru Ohashi, Naoki Takezako, Hina Takano, Yasuji Kouzai, Tadashi Murase, Matsue Kosei, Satoshi Morita, Junichi Sakamoto, Hisashi Wakita, Hisashi Sakamaki, Koiti Inokuchi, null null
Silent NK/T cell reactions to dasatinib during sustained deep molecular response before cessation are associated with longer treatment-free remission. Cancer science 111 (8) (2020)
Kazutaka Sunami, Matsue Kosei, Kenshi Suzuki, Naoki Takezako, Atsushi Shinagawa, Sanae Sakurai, Hiromi Tamakoshi, Tsvetan Biyukov, Teresa Peluso, Paul Richardson
Pomalidomide-bortezomib-dexamethasone in relapsed or refractory multiple myeloma: Japanese subset analysis of OPTIMISMM. Cancer science 111 (6) (2020)
Yuka Suzuki, Kei Kohno, Matsue Kosei, Ayako Sakakibara, Eri Ishikawa, Satoko Shimada, Kazuyuki Shimada, Seiyo Mabuchi, Taishi Takahara, Seiichi Kato, Shigeo Nakamura, Akira Satou
PD-L1 (SP142) expression in neoplastic cells predicts a poor prognosis for patients with intravascular large B-cell lymphoma treated with rituximab-based multi-agent chemotherapy. Cancer medicine 9 (13) (2020)
Matsue Kosei, Yoshiaki Abe, Kentaro Narita, Hiroki Kobayashi, Akihiro Kitadate, Masami Takeuchi, Daisuke Miura, Kengo Takeuchi
Diagnosis of intravascular large B cell lymphoma: novel insights into clinicopathological features from 42 patients at a single institution over 20 years. British journal of haematology 187 (3) (2019)
Matsue Kosei, Kyoya Kumagai, Isamu Sugiura, Takayuki Ishikawa, Tadahiko Igarashi, Tsutomu Sato, Michihiro Uchiyama, Toshihiro Miyamoto, Takaaki Ono, Yasunori Ueda, Toru Kiguchi, Yoshinori Sunaga, Toru Sasaki, Kenshi Suzuki
Plerixafor for mobilization and collection of haematopoietic stem cells for autologous transplantation in Japanese patients with non-Hodgkin lymphoma: a randomized phase 2 study. International journal of hematology 108 (5) (2018)
Sharna Tanzima Nuhat, Mamiko Sakata-Yanagimoto, Daisuke Komori, Keiichiro Hattori, Yasuhito Suehara, Kota Fukumoto, Manabu Fujisawa, Manabu Kusakabe, Matsue Kosei, Hirotake Wakamatsu, Mitsunobu Shimadzu, Shigeru Chiba
Droplet digital polymerase chain reaction assay and peptide nucleic acid-locked nucleic acid clamp method for RHOA mutation detection in angioimmunoblastic T-cell lymphoma. Cancer science 109 (5) (2018)
Kentaro Narita, Hiroki Kobayashi, Yoshiaki Abe, Hiroaki Kitadate, Masami Takeuchi, Matsue Kosei
Quantification of bone-marrow plasma cell levels using various International Myeloma Working Group response criteria in patients with multiple myeloma. International journal of hematology 108 (4) (2018)
Yoshiaki Abe, Yoshiaki Usui, Kentaro Narita, Masami Takeuchi, Matsue Kosei
Concomitant subcutaneous intravascular lymphoma lesions in a patient with cardiac diffuse large B-cell lymphoma: is intravascular lymphoma a distinct clinical entity? International journal of hematology 108 (6) (2018)
Hiroyuki Takamatsu, Rachel K Wee, Yoshitaka Zaimoku, Ryoichi Murata, Jianbiao Zheng, Martin Moorhead, Victoria E H Carlton, Katherine A Kong, Naoki Takezako, Shigeki Ito, Toshihiro Miyamoto, Kenji Yokoyama, Matsue Kosei, Tsutomu Sato, Toshiro Kurokawa, Hideo Yagi, Yasushi Terasaki, Kinya Ohata, Morio Matsumoto, Takashi Yoshida, Malek Faham, Shinji Nakao
A comparison of minimal residual disease detection in autografts among ASO-qPCR, droplet digital PCR, and next-generation sequencing in patients with multiple myeloma who underwent autologous stem cell transplantation. British journal of haematology 183 (4) (2017)
Takashi Kumagai, Chiaki Nakaseko, Kaichi Nishiwaki, Chikashi Yoshida, Kazuteru Ohashi, Naoki Takezako, Hina Takano, Yasuji Kouzai, Tadashi Murase, Matsue Kosei, Satoshi Morita, Junichi Sakamoto, Hisashi Wakita, Hisashi Sakamaki, Koiti Inokuchi, null null
Dasatinib cessation after deep molecular response exceeding 2 years and natural killer cell transition during dasatinib consolidation. Cancer science 109 (1) (2017)